Last updated 2026-07-20
Portfolio
1
in our dataset
Rounds participated
1
Rounds led
0
Rounds' value
$500K
total disclosed, rounds participated
Stages
—
About
Advanced Medical Technologies (ATI) develops medical devices for the ophthalmology market. Its products are designed to significantly improve the patient experience during diagnostic procedures while also increasing efficiency. The company's flagship product, Field-Induced Mydriasis (FIM), is a safe, non-contact, drug-free, and CE-approved pupil-dilation device. ATI is also developing NIT, a personal ocular tonometer for the early detection of glaucoma.
Portfolio · 1
Investment activity
Portfolio by sector
Health Tech & Life Sciences1
Q&A
- What is ATI Technologies' primary investment focus?
- ATI Technologies primarily invests in the Health Tech & Life Sciences sector, with Magen OrthoMed as a notable portfolio company.
- What is ATI Technologies' typical investment stage?
- ATI Technologies typically invests at the Seed stage. An example is their investment in Magen OrthoMed.
- Can you provide an example of a company in ATI Technologies' portfolio and its funding details?
- ATI Technologies invested in Magen OrthoMed, a B2B company founded in 2011 that develops adhesion barriers for scar prevention. Magen OrthoMed raised $500K in a Seed round.
- What is the typical check size for ATI Technologies?
- ATI Technologies' investment range is $500K. For instance, they invested $500K in Magen OrthoMed.
- Where is ATI Technologies headquartered?
- ATI Technologies is headquartered in Israel.
Full data — links, identifiers, deals & radar signals (jobs, patents, research, more)
Radar intelligence
Patents
| EPO | 2670 |
|---|